Literature DB >> 16301616

CD4+CD25+ T cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector T cells.

Richard J DiPaolo1, Deborah D Glass, Karen E Bijwaard, Ethan M Shevach.   

Abstract

Thymic-derived, naturally occurring, CD4+CD25+ regulatory T cells (nTreg) are potent suppressors of immune responses. A detailed understanding of which components of the development and activation of pathogenic effector T cells are inhibited by nTreg during the course of T cell-mediated, organ-specific autoimmunity is as yet unknown. We have analyzed the effects of polyclonal nTreg on the development of autoimmune gastritis. The nTreg inhibited the development of disease, but failed to inhibit the migration of effector cells into the gastric lymph node or stomach. Notably, nTreg did not inhibit the expansion of autoreactive T cells in the gastric lymph node. The primary effect of nTreg appeared to be inhibition of differentiation of autoantigen-specific T cells to Th1 effector cells, as reflected by a decrease in Ag-stimulated IFN-gamma production and a reduction in T-bet expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301616     DOI: 10.4049/jimmunol.175.11.7135

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis.

Authors:  H Keino; M Takeuchi; Y Usui; T Hattori; N Yamakawa; T Kezuka; J-I Sakai; M Usui
Journal:  Br J Ophthalmol       Date:  2006-08-30       Impact factor: 4.638

2.  Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cells.

Authors:  Adam T Hagymasi; Aaron M Slaiby; Marianne A Mihalyo; Harry Z Qui; David J Zammit; Leo Lefrancois; Adam J Adler
Journal:  J Immunol       Date:  2007-08-01       Impact factor: 5.422

Review 3.  Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target.

Authors:  Dorothy K Sojka; Yu-Hui Huang; Deborah J Fowell
Journal:  Immunology       Date:  2008-03-14       Impact factor: 7.397

Review 4.  Regulation of immunity at tissue sites of inflammation.

Authors:  Dorothy K Sojka; Christopher A Lazarski; Yu-Hui Huang; Irina Bromberg; Angela Hughson; Deborah J Fowell
Journal:  Immunol Res       Date:  2009-01-31       Impact factor: 2.829

5.  Induction of antigen-specific immune tolerance by TGF-beta-induced CD4+Foxp3+ regulatory T cells.

Authors:  Huimin Fan; Julie Wang; Xiaohui Zhou; Zhongmin Liu; Song Guo Zheng
Journal:  Int J Clin Exp Med       Date:  2009-08-25

6.  Autoimmunity to type VII collagen in SKH1 mice is independent of regulatory T cells.

Authors:  L Chen; J D Peterson; W-Y Zheng; S-X Lin; L S Chan
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 7.  Therapeutic potential of TGF-β-induced CD4(+) Foxp3(+) regulatory T cells in autoimmune diseases.

Authors:  Xiaohui Zhou; Ning Kong; Hejian Zou; David Brand; Xianpei Li; Zhongmin Liu; Song Guo Zheng
Journal:  Autoimmunity       Date:  2010-07-29       Impact factor: 2.815

8.  The Critical Role of TGF-beta1 in the Development of Induced Foxp3+ Regulatory T Cells.

Authors:  Song Guo Zheng
Journal:  Int J Clin Exp Med       Date:  2008-06-10

Review 9.  beta2-integrins in demyelinating disease: not adhering to the paradigm.

Authors:  Xianzhen Hu; Jillian E Wohler; Kari J Dugger; Scott R Barnum
Journal:  J Leukoc Biol       Date:  2009-12-09       Impact factor: 4.962

10.  Cutting edge: antigen-specific TGF beta-induced regulatory T cells suppress Th17-mediated autoimmune disease.

Authors:  Eva N Huter; Georg H Stummvoll; Richard J DiPaolo; Deborah D Glass; Ethan M Shevach
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.